Erika Gurzeler
Impact in
-
- Lipid metabolism and disorders
- Cardiac Fibrosis and Remodeling
- Cardiovascular Function and Risk Factors
Papers in
-
- Angiogenesis and VEGF in Cancer 3
- Congenital heart defects research 2
- Peroxisome Proliferator-Activated Receptors 1
- RNA and protein synthesis mechanisms 1
-
- Cardiomyopathy and Myosin Studies 3
- Lipid metabolism and disorders 2
- Co-authors
- Seppo Ylä‐Herttuala (14 shared papers)Jenni Huusko (8 shared papers)Kari Alitalo (3 shared papers)Mari Merentie (4 shared papers)Pasi Tavi (2 shared papers)Annukka M. Kivelä (4 shared papers)Marike H. Dijkstra (4 shared papers)Suvi E. Heinonen (4 shared papers)
- Journals
- Molecular Therapy (2 papers)Atherosclerosis (2 papers)PLoS ONE (2 papers)European Heart Journal (1 paper)Frontiers in Bioengineering and Biotechnology (1 paper)
- Partner nations
- FinlandSwedenUnited Kingdom
In The Last Decade
Erika Gurzeler
14 papers receiving 240 citations
Peers
Comparison fields: 5 of 48
- Cardiology and Cardiovascular Medicine 75
- Cancer Research 31
- Immunology 36
- Molecular Biology 118
- Immunology and Allergy 7
Countries citing papers authored by Erika Gurzeler
This map shows the geographic impact of Erika Gurzeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Gurzeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Gurzeler more than expected).
Fields of papers citing papers by Erika Gurzeler
This network shows the impact of papers produced by Erika Gurzeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Gurzeler. The network helps show where Erika Gurzeler may publish in the future.
Co-authors
The 25 scholars most cited alongside Erika Gurzeler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 64 | |
| 2 | 2013 | 52 | |
| 3 | 2015 | 48 | |
| 4 | 2012 | 23 | |
| 5 | 2018 | 16 | |
| 6 | 2017 | 15 | |
| 7 | 2017 | 6 | |
| 8 | 2022 | 5 | |
| 9 | 2018 | 3 | |
| 10 | 2017 | 3 | |
| 11 | 2018 | 2 | |
| 12 | 2025 | 2 | |
| 13 | 2021 | 1 | |
| 14 | 2013 | 1 |
About Erika Gurzeler
Erika Gurzeler is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Surgery, Immunology and Pathology and Forensic Medicine, having authored 14 papers that have together received 241 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (3 papers), Cardiomyopathy and Myosin Studies (3 papers), Coronary Interventions and Diagnostics (2 papers), Congenital heart defects research (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), Lipid metabolism and disorders (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper) and RNA and protein synthesis mechanisms (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (75 citations), Cancer Research (31 citations), Immunology (36 citations), Molecular Biology (118 citations) and Immunology and Allergy (7 citations). Erika Gurzeler has collaborated with scholars based in Finland, Sweden and United Kingdom. Frequent co-authors include Seppo Ylä‐Herttuala, Jenni Huusko, Kari Alitalo, Mari Merentie, Pasi Tavi, Annukka M. Kivelä, Marike H. Dijkstra, Suvi E. Heinonen, Andrey Anisimov and Petri I. Mäkinen. Their work appears in journals such as Molecular Therapy, Atherosclerosis, PLoS ONE, European Heart Journal and Frontiers in Bioengineering and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.